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T lymphocytes rely on a Ca21 signal known as store-operated calcium entry (SOCE) for their activation. This
Ca21 signal is generated by activation of a T-cell receptor, depletion of endoplasmic reticulum (ER) Ca21
stores and activation of Ca21 release-activated Ca21 currents (ICRAC). Here, we report that the ER protein oro-
somucoid like 3 (ORMDL3), the product of the ORMDL3 gene associated with several autoimmune and/or in-
flammatory diseases, negatively modulates ICRAC, SOCE, nuclear factor of activated T cells nuclear
translocation and interleukin-2 production. ORMDL3 inhibits the Ca21 influx mechanism at the outer mito-
chondrial membrane, resulting in a Ca21-dependent inhibition of ICRAC and reduced SOCE. The effect of
ORMDL3 could be mimicked by interventions that decreased mitochondrial Ca21 influx and reverted by buf-
fering of cytosolic Ca21 or activation of mitochondrial Ca21 influx. In conclusion, ORMDL3 modifies key steps
in the process of T-lymphocyte activation, providing a functional link between the genetic associations of the
ORMDL3 gene with autoimmune and/or inflammatory diseases.
INTRODUCTION
Calcium homeostasis and activation in many cells rely on a
Ca2+ signal originated via a mechanism known as store-oper-
ated calcium entry (SOCE) (1), which in the case of T lympho-
cytes is of particular relevance and is triggered following
antigen binding to the T-cell receptor and endoplasmic reticu-
lum (ER) Ca2+ depletion (2). The major Ca2+ sensor in the
ER, the stromal interaction molecule 1 (STIM1) (3,4), acti-
vates plasma membrane-localized Orai channels (5), ultimate-
ly giving rise to what is known as the Ca2+ release-activated
Ca2+ current (ICRAC) (6). Similarly, activation of other immune
cells, such as mast cells or dendritic cells, also depends on
the influx of Ca2+ into the cytosol (reviewed in 7). Ca2+
signals generated by Orai channels promote the translocation
of several transcription factors to the nucleus, the nuclear
factor of activated T cells (NFAT) particularly being relevant
to lymphocyte physiology (8). Activation and translocation of
NFAT, in turn, trigger the transcription of different genes
related to T-cell activation such as interleukin 2 (IL-2) (9,10).
Several proteins have been recently reported to modulate
CRAC channel-mediated Ca2+ signals at different levels.
CRACR2A is a cytosolic protein that stabilizes the STIM–
Orai interaction in a Ca2+-dependent manner, thereby enhan-
cing SOCE (11). Two other proteins, Golli (12,13) and stan-
niocalcin 2 (14), interact with STIM1 reducing SOCE.
CRAC channels are also regulated by a negative feedback
mechanism known as calcium-dependent inactivation (CDI)
due to the accumulation of Ca2+ in the immediate vicinity
of the channels (15–17). Two proteins have been described
to participate in this process. Interaction of calmodulin with
both STIM1 and Orai1 triggers rapid CDI of the CRAC
channel (18), while the ER protein SARAF associates with
STIM to facilitate slow CDI (19).
†The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.
∗To whom correspondence should be addressed at: Laboratory of Molecular Physiology and Channelopathies, Universitat Pompeu Fabra, Parc de
Recerca Biome`dica de Barcelona, Room 341, C/Dr Aiguader 88, Barcelona 08003, Spain. Tel: +34 933160854; Fax: +34 933160901; Email:
ruben.vicente@upf.edu
# The Author 2012. Published by Oxford University Press. All rights reserved.
For Permissions, please email: journals.permissions@oup.com
Human Molecular Genetics, 2013, Vol. 22, No. 3 519–530
doi:10.1093/hmg/dds450
Advance Access published on October 25, 2012
The calcium buffering system of the cell, which includes
Ca2+ uptake into the ER and mitochondria as well as extrusion
via the plasma membrane, also modulates ICRAC current by
preventing CDI (20–25). In this context, it is important to
point out that ER and mitochondrial shaping of calcium
signals may be functionally connected at the mitochondrial-
associated membranes (MAMs) (26) which are the zones of
close contact between these organelles. Several proteins act
as tethering sites at MAMs, including calcium transporters
such as the sarco-endoplasmic calcium ATPase pump
(SERCA) and inositol trisphosphate receptors in the ER mem-
brane and the voltage-dependent anion channel in the outer
mitochondrial membrane (26,27).
The ER-resident transmembrane protein orosomucoid like 3
(ORMDL3) (28) regulates ER calcium homeostasis via inhib-
ition of SERCA2b (29) and modulates the unfolded protein re-
sponse (29,30). ORMDL3 is coded by the ORMDL3 gene,
whose expression has been reported in the cells that participate
in the inflammatory response such as T lymphocytes (28,31).
Single nucleotide polymorphisms located in the regulatory
regions modify ORMDL3 expression levels and have been
associated with different immune-mediated inflammatory dis-
eases such as asthma, ulcerative colitis, type 1 diabetes and
Crohn’s disease (30–33). All these diseases also share a de-
regulation of T-lymphocyte activation (33–36).
Given the findings that (1) ORMDL3 is associated with
several inflammatory and autoimmune diseases; (2) ORMDL3
regulates ER Ca2+ homeostasis; (3) Ca2+ influx is essential
for triggering T-lymphocyte activation and (4) T-lymphocyte
activation is a key step in the proinflammatory response; we
postulate that ORMDL3 expression might be affecting
SOCE and T-lymphocyte activation.
RESULTS
ORMDL3 alters cytoplasmic calcium levels and ER Ca21
release in lymphocytes
To elucidate the role of ORMDL3 in lymphocyte physiology
and the link between genetic associations of the ORMDL3
gene with autoimmune and/or inflammatory diseases, we
have investigated the impact of ORMDL3 on Ca2+ homeosta-
sis and activation of Jurkat T cells.
We first reassessed whether the effect of ORMDL3 overex-
pression on the cytoplasmic and ER Ca2+ levels in Jurkat T
cells was similar to what was previously reported for
HEK293 cells (29). ORMDL3 overexpression in Jurkat T
cells increased cytoplasmic Ca2+ (Fig. 1A) and decreased
the ER Ca2+ release triggered by the SERCA inhibitor cyclo-
piazonic acid (CPA, 30 mM), which mainly reflects the amount
of Ca2+ stored in the ER (Fig. 1B and C). Similar results were
obtained with the siRNA-mediated knockdown of the SERCA
pump (Fig. 1A, D and E), thereby confirming our previous
results that proposed the interaction of ORMDL3 with
SERCA causing the inhibition of the pump (29). ORMDL3
knockdown with siRNA increased ER Ca2+ release (Fig. 1D
and E) with no apparent effect on basal cytoplasmic Ca2+
(Fig. 1A).
ORMDL3 regulates store-operated calcium entry
Ca2+ signaling is of paramount importance in immune system
physiology. Indeed, activation of T cells depends on a sus-
tained increase in cytosolic Ca2+ concentration through
SOCE (7,8). We evaluated SOCE in transiently transfected
Jurkat T cells incubated with anti-CD3 antibody and stimu-
lated with a secondary antibody that promotes TCR aggrega-
tion and SOCE (Fig. 2). ORMDL3 overexpression reduced
Ca2+ entry, seen upon addition of Ca2+ to the extracellular
medium, compared with its control ORMDL3-△1-16
(Fig. 2A and B), an ORMDL3 mutant lacking the cytosolic N-
terminal domain. This N-terminal sequence is not present in
the yeast orthologs, Orms (Supplementary Material,
Fig. S1A and B). When expressed in Jurkat T lymphocytes
and HEK293 cells, ORMDL3- △1-16 showed the same char-
acteristics as GFP transfected control cells (Supplementary
Material, Fig. S1C and D). Thereafter, this mutant was used
as a control in overexpression experiments. On the other
hand, siRNA-mediated knockdown of ORMDL3 increased
SOCE after CD3 stimulation (Fig. 2C and D).
ORMDL3 modulates Ca21 released-activated Ca21
currents
Ca2+ influx following depletion of ER stores occurs through
what is classically known as the CRAC channel, formed by
the Orai protein (37–39). We analyzed endogenous whole-cell
CRAC current (ICRAC) in Jurkat T cells transiently transfected
with ORMDL3-WT or ORMDL3-△1-16 (Fig. 3A–C). In
order to passively deplete ER stores and activate ICRAC, we
included the Ca2+ chelator EGTA (10 mM) in the internal
pipette solution (6). Our results show that compared with the
cells overexpressing ORMDL3- △1-16, the cells overexpres-
sing ORMDL3-WT presented a decrease in current density
and a delay in the development of the current (Fig. 3A–C).
Downregulation of ORMDL3 expression with siRNA pro-
voked an increase in current density and a faster development
of ICRAC compared with control siRNA (Fig. 3D–F).
Yeast ORMDL3 orthologs, Orms, are implicated in
sphingolipid metabolism (40,41). Orms inhibit serin palmi-
toyltranferase (SPT) and block the sphingolipid biosynthetic
pathway, although at present it is not known whether a
similar function is preserved in mammalian ORMDLs. Myrio-
cin is a specific inhibitor of the SPT that has been previously
used as a pharmacological tool to mimic Orms function
(40,41). However, treatment with 10 mg/ml myriocin for
24 h did not affect the current density or the delay time of
ICRAC (Supplementary Material, Fig. S2).
ORMDL3 modifies lymphocyte activation
A sustained Ca2+ concentration increase in the cytoplasm pro-
motes NFAT dephosphorylation and its nuclear translocation
(8). We tested NFAT nuclear translocation by confocal mi-
croscopy in resting and activated Jurkat T lymphocytes. To
monitor NFAT location, we overexpressed a NFAT1–GFP
fusion protein and quantified the NFAT1–GFP signal
present in the nucleus at 30 and 6 h after activation with
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thapsigargine (TG, 1 mM) plus phorbol 12-myristate 13-acetate
(PMA, 20 nM) (Fig. 4A and B).
Compared with ORMDL3-△1-16, overexpression of
ORMDL3-WT reduced the translocation of NFAT to the
nucleus in activated cells (Fig. 4A), while siRNA-mediated
downregulation of ORMDL3 was associated with higher
NFAT translocation 6 h after activation (Fig. 4B). However,
no difference in NFAT translocation was observed under
these conditions at 30 min. These results are in agreement
with previous data showing that reduction of as much as
50% of the SOCE response mainly impacts on the late phase
of NFAT translocation (42).
One of the earliest genes transcribed following the activa-
tion program in T cells and used as an early marker of activa-
tion is IL-2. We tested IL-2-positive cells using a flow
cytometry-based intracellular staining technique in Jurkat T
cells in which ORMDL3 was overexpressed or downregulated
(Fig. 4C and D). The cells were activated as described above
Figure 1. Effect of ORMDL3 on cytosolic calcium levels and ER release in Jurkat T cells. (A) Basal cytosolic [Ca2+] in cells transfected with empty vector (n ¼
15), ORMDL3-WT (n ¼ 25), control siRNA (n ¼ 25), ORMDL3 siRNA (n ¼ 25) and SERCA siRNA (n ¼ 15). ∗P ¼ 0.013, ∗∗P ¼ 0.002. (B–E) Ca2+ signals
generated by addition of 30 mM CPA to a Ca2+-free containing solution to promote the passive release of Ca2+ from ER. (B) Time course and (C) mean peak
values obtained from the cells transfected with ORMDL3-WT (n ¼ 111) and empty vector (n ¼ 92). ∗∗P ¼ 0.0001. (D) Time course and (E) the mean peak
values from the cells transfected with ORMDL3 siRNA (n ¼ 76), control siRNA (n ¼ 65) and SERCA siRNA (N ¼ 49). ∗P ¼ 0.03, ∗∗P ¼ 0.0001. Data are
presented as mean+SEM.
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and 6 h after activation a population of cells producing IL-2
showed up. This population was reduced in the cells over-
expressing ORMDL3-WT compared with the cells over-
expressing ORMDL3-△1-16 (Fig. 4C). Downregulation of
ORMDL3 expression with siRNA resulted in an increased
population of cells producing IL-2 (Fig. 4D).
ORMDL3 localizes near STIM–Orai puncta
The trigger for the opening of CRAC channels involves the
interaction between STIM proteins located in the ER and
Orai proteins present in the plasma membrane (43). We ana-
lyzed whether ORMDL3 colocalized with STIM1 and Orai1.
A line scan of confocal images of cells overexpressing
Orai1-YFP, STIM1-CFP and either ORMDL3-WT or
ORMDL3-△1-16 showed that both ORMDLs colocalized
with STIM1 in unstimulated cells and moved with STIM1
towards the plasma membrane puncta upon activation of
Jurkat T cells (Supplementary Material, Fig. S3). However,
we ruled out the possibility that ORMDL3 interacts directly
with STIM as no coimmunoprecipitation was detected
between ORMDL3 and this protein (Supplementary Material,
Fig. S4). Similar colocalization results were obtained for the
ORMDL3-△1-16 mutant, thereby discarding misslocalization
of the mutant ORMDL3 as the reason for its lack of function.
Besides, the differences in ICRAC and SOCE observed follow-
ing alteration of ORMDL3 expression levels were not due to
differences in the expression of STIM1 or Orai1, which
remained unmodified (Supplementary Material, Fig. S4).
ORMDL3 increases ICRAC calcium-dependent inactivation
CRAC channel activity is negatively regulated by cytosolic
Ca2+ levels in both a fast and slow time scale (15–17), a
process that is prevented with strong buffering of the intracel-
lular Ca2+. In order to explore whether the mechanism behind
ORMDL3 modulation of SOCE was related to CDI of CRAC
channels, we recorded endogenous whole-cell ICRAC using the
fast Ca2+ chelator BAPTA (as slow CDI is not fully prevented
in the presence of 10 mM EGTA (44,45)) in the internal solu-
tion of the patch pipette. In the presence of BAPTA, ORMDL3
overexpression did not produce any effect on ICRAC develop-
ment or the current density (Fig. 5A and B). This result sug-
gested that ORMDL3 affects ICRAC CDI. To further explore
Figure 2. Effect of ORMDL3 on SOCE in Jurkat T cells. Cytosolic Ca2+ levels evaluated in the cells preincubated with mouse anti-human CD3. ER Ca2+
release triggered by addition of anti-Fc-specific antibody (1:100) to a Ca2+-free solution and SOCE evaluated following readdition of Ca2+ to the bathing so-
lution. (A and B) Time course and mean peak values obtained from the cells transfected with ORMDL3-WT (n ¼ 67) and ORMDL3-D1-16 (n ¼ 60). ∗∗P ¼
0.0026. (C) Time course and (D) mean peak values obtained from the cells transfected with ORMDL3 siRNA (n ¼ 54) and control siRNA (n ¼ 43). ∗∗P ¼
0.01. Data are presented as mean+SEM.
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whether ORMDL3 affects slow CDI, the cells were incubated
in Ca2+-free solutions containing TG (1 mM) and recorded
with weak intracellular Ca2+ buffering. Upon addition of
Ca2+ to the bath solution, ICRAC developed (represented as
percentage of the maximal current), showing a faster
rundown in ORMDL3-WT transfected cells compared with
ORMDL3-△1-16 expressing cells (Fig. 5C and E). An add-
ition of high concentrations of the slow Ca2+ chelator
EGTA (20 mM) to the pipette solution abolished the
ORMDL3-induced slow CDI of ICRAC (Fig. 5D and F). To-
gether these experiments suggested an ORMDL3-dependent
modulation of ICRAC CDI.
ORMDL3 binds to and inhibits the SERCA pump promot-
ing cytosolic calcium accumulation (29), although several
pieces of evidence argue against the ORMDL3-dependent in-
hibition of SERCA as the cause of the increased ICRAC CDI
observed in the cells overexpressing ORMDL3. First, the
ORMDL3-dependent effect on ICRAC slow CDI appeared
in the presence of the irreversible SERCA inhibitor TG
(Fig. 5C). Second, we obtained a similar reduction in SOCE
response when we applied CPA (Supplementary Material,
Fig. S5A) or anti-CD3 (Fig. 2A). Third, siRNA-mediated
knockdown of SERCA reduced the CPA-induced ER Ca2+
release but did not affect SOCE (Supplementary Material,
Figure 3. ORMDL3 expression modifies endogenous ICRAC currents in Jurkat T cells. (A) ICRAC current–voltage ramps recorded from Jurkat T cells overex-
pressing ORMDL3-D1-16 or ORMDL3-WT at t ¼ s. (B), Time course of the current density recorded at 280 mV (symbols) and +80 mV (lines) in Jurkat cells
overexpressing ORMDL3-D1-16 (black) and ORMDL3-WT (white, grey). (C) Time constant of ICRAC development (left) and mean peak current density
recorded at 280mV (right) in Jurkat cells overexpressing ORMDL3-D1-16 and ORMDL3-WT current delay ∗P ¼ 0.01 and current density ∗P ¼ 0.02. (D)
ICRAC current–voltage ramps recorded from Jurkat T cells transfected with control siRNA or ORMDL3 siRNA. (E) Time course of current density recorded
at 280 mV (symbols) and +80 mV (lines) in Jurkat cells transfected with control siRNA (black) or ORMDL3 siRNA (white,grey). (F) Time constant of
ICRAC development (left) and mean peak current density recorded at 280mV (right) in Jurkat cells transfected with control siRNA or ORMDL3 siRNA.
Current delay ∗P ¼ 0.04 and current density ∗P ¼ 0.02. ORMDL3-D1-16 (n ¼ 13); ORMDL3-WT (n ¼ 13); control siRNA (n ¼ 10); ORMDL3 siRNA
(n ¼ 10). Data are presented as mean+SEM.
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Fig. S5B). Altogether, these results suggested the participation
of a mechanism different from the ORMDL3-mediated inhib-
ition of SERCA in the ORMDL3-mediated modulation of
SOCE in Jurkat T cells.
ORMDL3 reduces mitochondrial calcium uptake
In an attempt to identify the mechanism of ORMDL3-
dependent modulation of SOCE, we focused our attention on
mitochondria as Ca2+ influx into these organelles modulates
ICRAC CDI and SOCE (23,24,46).
Punctual colocalization of ORMDL3 with mitotracker was
detected in Jurkat cells (Supplementary Material, Fig. S6A),
which was similar to that described for ER proteins present at
the ER–mitochondria junctions (27). Application of antimycin
A and oligomycin (which both depolarize mitochondrial poten-
tial and thereby impair Ca2+ uptake into the mitochondria (47))
reduced SOCE in ORMDL3-D1-16 expressing cells to the level
seen in ORMDL3-WT expressing cells (Fig. 6A, left). On the
other hand, kaempferol, an activator of the mitochondrial
Ca2+ uniporter (48), reverted the ORMDL3-induced SOCE
phenotype back to control (ORMDL3-D1-16) levels (Fig. 6A,
middle). Together, these experiments showed that the effect of
ORMDL3 overexpression on SOCE was mimicked by pharma-
cological manipulation of mitochondrial Ca2+ influx (Fig. 6A
right). Next, we evaluated whether ORMDL3 could affect
Ca2+ influx into the mitochondria using a mitochondrially tar-
geted GFP-based ratiometric Pericam Ca2+ sensor (mtPeri-
camR) (49) and the low Ca2+ affinity dye rhod-5N (50).
We evaluated mitochondrial Ca2+ uptake in permeabilized
Jurkat T cells expressing mtPericamR and ORMDL3-WT or
ORMDL3-D1-16 exposed to identical [Ca2+]cyt. Following
the permeabilization of the plasma membrane with digitonin
under Ca2+-free conditions, Ca2+ was added to the external
solution to trigger mitochondrial Ca2+ influx. Under these
conditions, Ca2+ influx into the mitochondria of ORMDL3-
expressing cells was lower than in ORMDL3-D1-16 expres-
sing cells (Fig. 6B), pointing to a deficient mitochondrial
Ca2+ influx as the primary cause of increased ICRAC CDI
and reduced SOCE. Opposite results of mitochondrial uptake
were obtained downregulating ORMDL3 with siRNAs
(Fig. 6C). Similar changes in mitochondrial [Ca2+] were
obtained using CPA in non-permeabilized cells or using the
calcium dye rhod-5N (Supplementary Material, Fig. S6).
Finally, considering that removal of the N-terminus renders
ORMDL3 unable to regulate SOCE, we tested the effect of
Figure 4. ORMDL3 modulates nuclear NFAT1 translocation. (A and B) Representative images showing NFAT1-GFP (green) and TO-PRO (red) for every trans-
fection condition at basal and 6 h after activation with PMA (20 nM) and thapsigargine (TG, 1 mM). The quantification of NFAT1 present in the nucleus was
obtained dividing the nuclear signal of NFAT-GFP (colocalizing with TO-PRO) by the total NFAT1-GFP signal for each cell. (A) (right) mean values of
nuclear NFAT1 present at basal, 30 min and 6 h in cells overexpressing ORMDL3-D1-16 (n ¼ 39) or ORMDL3-WT (n ¼ 103). ∗P ¼ 0.0001. (B) (right)
mean values of nuclear NFAT1 present at basal, 30 min and 6 h in cells overexpressing control siRNA (n ¼ 17) or ORMDL3 siRNA (n ¼ 17). ∗P ¼ 0.02.
(C and D) Jurkat T cells were cotransfected with GFP and ORMDL3-D1-16, ORMDL3-WT, control siRNA or ORMDL3 siRNA. 24 h after transfection
cells were activated with PMA (20 nM) and TG (1 mM) for 6 h and stained using an IL-2 antibody. A minimum of 3000 GFP-positive cells were taken for
each experiment. (C) Mean percentage of IL-2-positive cells under ORMDL3-WT conditions referred to ORMDL3-D1-16 (n ¼ 3). ∗P ¼ 0.03. (D) Mean per-
centage of IL-2-positive cells under ORMDL3 siRNA conditions referred to control siRNA (n ¼ 6). ∗P ¼ 0.0002. Data are presented as mean+SEM.
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the N-terminus isolated from the rest of the protein. Overex-
pression of amino acids 1–20 of ORMDL3 mimicked the
effect of the whole ORMDL3 protein on SOCE and mitochon-
drial Ca2+ influx (Fig. 6D and E). Altogether, our results indi-
cated that ORMDL3 affects mitochondrial Ca2+ influx and the
Ca2+ buffering capacity of the cell, thereby affecting the CDI
of CRAC channels.
DISCUSSION
The association of the ORMDL3 gene with several proinflam-
matory and autoimmune diseases suggests that ORMDL3
protein may play an important role in the immune system
physiology. Cells of the immune system express ORMDL3
(28,31) and increased expression of ORMDL3 has been
Figure 5. ORMDL3 increases ICRAC CDI: (A) ICRAC current–voltage ramps recorded from Jurkat T cells overexpressing ORMDL3-D1-16 or ORMDL3-WT at
t ¼ 283 s in the presence of 10 mM BAPTA in the pipette. (B) Time course of current density recorded at 280 mV (symbols) and +80 mV (lines) in Jurkat T
cells dialyzed with BAPTA and overexpressing ORMDL3-D1-16 (black, n ¼ 5) or ORMDL3-WT (white, grey; n ¼ 6). (C) Time course of normalized current
(ICRAC/ICRACmax) recorded at 2100 mV in Jurkat T cells dialyzed with 1.2 mM EGTA after depletion of intracellular stores with TG and addition of 20 mM Ca
2+
to the bathing solution (ORMDL3-D1-16, n ¼ 7; and ORMDL3-WT, n ¼ 6). (D) Normalized mean currents recorded as in (C) but using pipette solutions con-
taining 20 mM EGTA (ORMDL3-D1-16, n ¼ 7; and ORMDL3-WT, n ¼ 6) (E) Mean normalized current measured at three different times (from C): in the
absence of calcium (left), peak (middle) and current remaining at 5 min (right) following the addition of Ca2+. (F) Mean normalized current measured at
three different times (from D): in the absence of calcium (left), peak (middle) and current remaining at 5 min (right) following the addition of Ca2+.
∗P ¼ 0.01. Data are presented as mean+SEM.
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associated with higher risk of childhood asthma (31). We have
previously shown that the product of this gene is an ER protein
that participates in ER-mediated Ca2+ homeostasis and stress
responses (29), thereby providing a link between asthma,
ORMDL3 and dysregulation of Ca2+ homeostasis. Additional
support for the hypothesis that genetic variants with impact in
Ca2+ homeostasis are relevant to asthma pathophysiology
comes from an association study of transient receptor potential
cationic channels with the severity of childhood asthma
(51)(reviewed by 52). In the present study, we have carried
out a deeper evaluation of ORMDL3 function focusing on
the impact of ORMDL3 on SOCE and lymphocyte activation.
Our results show that ORMDL3 modulates SOCE and
lymphocyte activation, an effect that may sum to the previous-
ly described effect on ER Ca2+ imbalance and stress (29).
We have shown that overexpression of ORMDL3 decreases
SOCE and T-cell activation. Impaired Ca2+ signaling in T
cells has been linked to inherited immunodeficiency diseases
Figure 6. ORMDL3 affects mitochondrial buffering capability. Left, SOCE in cells transfected with ORMDL3-△1-16 in the presence or absence of oligomycin
and antimycin (A) (O/A) to depolarize the mitochondria. Middle, SOCE in cells transfected with ORMDL3-WT in the presence (n ¼ 50) or absence (n ¼ 75) of
kampferol, an activator of the mitocondria Ca2+ uniporter. Right, mean peak responses. ∗P ¼ 0.0001. (B and C) Mitochondrial Ca2+ signal measured using the
mtPericam sensor after readdition of extracellular Ca2+ to Jurkat cells overexpressing ORMDL3-D1-16 (n ¼ 25) or ORMDL3-WT (n ¼ 18, ∗P ¼ 0.04); or
exposed to ORMDL3 siRNA (n ¼ 27) and control siRNA (n ¼ 40; ∗P ¼ 0.01). Cells were pretreated with 10 mM digitonin in a free calcium external solution
(D) SOCE elicited by anti-human CD3 preincubated Jurkat T cells was carried out as described in Fig. 2. Expression of ORMDL3-Nter (n ¼ 48) decreased
SOCE compared with empty vector (n ¼ 38; ∗P ¼ 0.02). (E) Mitochondrial calcium uptake using a mtPericam sensor in Jurkat cells expressing either
ORMDL3-Nter (n ¼ 58) or an empty vector (n ¼ 57; ∗P ¼ 0.03). Data are presented as mean+SEM.
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(37) but evidences also exist linking deficient T-cell Ca2+ sig-
naling to proinflammatory conditions. Mice lacking both
STIM1 and STIM2 present an impaired SOCE but show
splenomegaly, lymphadenopathy and leukocyte infiltration in
several tissues, including lungs, due to anomalous regulatory
T-lymphocyte development (42,53). Similarly, ablation of
the signaling cascade downstream SOCE (e.g. NFAT (54))
or mutations in the upstream signaling elements (in the
linker for activation of T cells (LAT) that prevent PLCg acti-
vation (55,56)) resulted in mice presenting lymphoprolifera-
tive and autoimmune phenotypes. In summary, it is possible
that disruption of the fine tuning of the SOCE-NFAT
pathway determines T-cell dysfunction, which may be
expressed at the individual level as proinflammatory or immu-
nodeficient conditions. It is not yet known how ORMDL3 may
be affecting the immune system in animal models but the fact
that it modulates lymphocyte activation suggests that it may
also have an impact on the overall immune system response.
Our results demonstrate that ORMDL3 modifies SOCE
response by altering the slow CDI of the CRAC channel, an
effect that requires the N-terminus of the protein, which is suf-
ficient to induce modulation of the SOCE. ORMDL3 binds to
and inhibits the SERCA pump (29) reducing the ER calcium
content. Both, SERCA (21) and ORMDL3 (this study), localize
close to the STIM-Orai interaction sites in activated lympho-
cytes. However, ORMDL3-mediated modulation of ICRAC and
SOCE is independent of SERCA activity since these effects
are observed in the presence of SERCA inhibitors.
In our search for factors that may explain the ORMDL3-
mediated differences in ICRAC and SOCE, we focused on the
mitochondria as these organelles are found in close proximity
to both the ER and the plasma membrane (26,57) and are
capable of modulating Ca2+ signals (58,59). Through their
ability to take up cytoplasmic Ca2+, mitochondria exert a
dual effect on SOCE. Mitochondrial competition for the
Ca2+ used by SERCA to refill the ER initially enhances
ICRAC activation (accelerating ICRAC development), while in
a slower time scale reduces inactivation of CRAC channels
(23,46,60,61). Besides that, mitochondria migrate near Orai
channels during SOCE activation and formation of an im-
munological synapse, further favoring the removal of
calcium from the channel vicinity and preventing CDI
(62,63). Mitochondria has also been recently proposed to
exert a permissive role in STIM1 trafficking (64).
The fact that mitochondrial Ca2+ uptake is impaired in
ORMDL3 overexpressing cells and enhanced by knocking
down ORMDL3 with siRNA may explain the effect of
ORMDL3 on ICRAC and SOCE. Several pieces of evidence
support this conclusion. First, depolarization of the mitochon-
drial potential, preventing mitochondrial calcium buffering
capacity, mimics the ORMDL3 effect on SOCE, while favor-
ing mitochondrial Ca2+ import upon application of kaempferol
reverts the effect of ORMDL3 on SOCE. Second, the changes
in ICRAC development vary according to a reduced mitochon-
drial Ca2+ influx (increased delay in ORMDL3 overexpressing
cells) or increased mitochondrial Ca2+ influx (reduced delay
in ORMDL3 siRNA-treated cells). Third, augmented ICRAC
CDI in ORMDL3 expressing cells is also consistent with a
reduced mitochondrial Ca2+ influx. The fact that high concen-
tration of EGTA (and lower concentration of BAPTA) reduced
the ORMDL3-induced CDI of ICRAC along with the involve-
ment of the mitochondria in this process suggests that
ORMDL3 affects ICRAC slow CDI. Fourth, the ORMDL3-
mediated changes in mitochondrial Ca2+ influx are not sec-
ondary to alterations in SOCE as similar changes were
obtained in permeabilized cells exposed to the same [Ca2+].
Fifth, we observed punctual colocalization of ORMDL3 with
mitochondria, similar to that described for the physical inter-
acting spots between ER and mitochondria called MAMs
(26). We have not evaluated whether ORMDL3 may be also
affecting the metabolic activity and the ATP production at
the mitochondria, which in turn may be affecting the
SERCA pump activity and ER calcium refilling (65).
Yeast orthologs of ORMDL3 (Orms) participate in sphingo-
lipid metabolism and stress pathways (40,41). However, in our
hands myriocin did not affect ICRAC in Jurkat T cells. More-
over, the N-terminus region of Orms, essential for its activity
regulation (66–68), is not conserved in mammals. Neverthe-
less, our experiments with the ORMDL3-△1-16 mutant and
the overexpression of the N-terminus alone demonstrate that
the residues present in the mammalian N-terminus are essen-
tial for the ORMDL3 activity.
In conclusion, we have shown that ORMDL3 expression
levels modify T-cell calcium signaling and lymphocyte activa-
tion following the alteration of the mitochondrial Ca2+ influx
and ICRAC CDI. Our data point to ORMDL3 as the first
ER-based protein modulating Ca2+ transport into the mito-
chondria and places it at an important position in the control
of Ca2+ transport into the major intracellular stores. Moreover,
our data offer a pathophysiological mechanism, the regulation
of SOCE and lymphocyte activation, by which ORMDL3 may
be participating in those immune and/or inflammatory diseases
showing altered levels of ORMDL3 expression.
MATERIALS AND METHODS
Reagents, plasmids and cell culture
Jurkat T cells were maintained in Roswell Park Memorial Insti-
tute medium plus 10% fetal bovine serum (FBS) and HEK293
cells were cultured in Dulbecco’s modified Eagle’s medium
plus 10% FBS. Transient transfection of Jurkat T cells and
HEK293 cells was carried out using TransIT-Jurkat transfec-
tion reagent (Mirus Bio Corporation) and ExGen500 (Fermen-
tas MBI), respectively.
Activation of Jurkat T cells was carried out with phorbol-
12-myristate-13-acetate (PMA, 20 nM) and TG (1 mM) for
6 h. For those experiments using myriocin (10 mg/ml) to
inhibit the serine palmitoyltranferase enzyme, the cells were
treated for 24 h. All chemicals unless otherwise indicated
were obtained from Sigma.
ORMDL3 amino terminal deletion (ORMDL3-D1-16) was
generated by PCR and cloned into pCDNA3 vector. The se-
quence of the ORMDL3 N-terminus was cloned in a
pcmv-myc expressing vector (ORMDL3-Nter) producing the
following fusion peptide MASMQKLISEEDLLMAMEAR-
ILNVGTAHSEVNPNTRVMNSR. NFAT1 expression vector
was a kind gift from Dr J. Aramburu (Universitat Pompeu
Fabra), pmaxSTIM1-CFP and pmaxOrai1-YFP were a gentle
gift from Dr Samelson LE (National Cancer Institute,
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Bethesda). All constructs were verified by sequencing (Big
Dye 3.1, AbiPrism, Applied Biosystems).
ORMDL3 siRNA (5′-TAAGTACGACCAGATCCATTT-3′)
(Qiagen) or control siRNA (5′-AATTCTCCGAACGTGT-
CACGT-3′) (Qiagen) was used in the expression knockdown
experiments (29). SERCA siRNA was purchased from Invitro-
gen. These siRNAs were transfected using Lipofectamin 2000
(Invitrogen).
Measurement of intracellular [Ca21]
A cytosolic Ca2+ signal was determined in cells loaded with
4.5 mM fura-2.AM (20 min) as previously described (69).
Cytosolic [Ca2+] increases are presented as the ratio of
emitted fluorescence (510 nm) after excitation at 340 and
380 nm, relative to the ratio measured prior to cell stimulation
(fura-2 ratio 340/380).
Mitochondrial calcium levels were obtained in cells loaded
for 15 min at 378C with 5 mM rhodamine-5N-AM (50) or trans-
fected with mtPericamR (49). Calcium increases in rhodamine-
loaded cells are presented as an increase in emitted fluorescence
(590 nm) after excitation (561 nm). Ratiometric-pericam-mt
imagingwas obtained by excitation at 410 and 488 nmand emis-
sion at 520 nm in a Leica TCS SP5 confocal microscope with a
40× Oil objective and analyzed using ImageJ software. All
experiments were carried out at room temperature and the
cells were bathed in a solution containing (in mM): 140 NaCl,
5 KCl, 1.2 CaCl2, 0.5 MgCl2, 5 glucose, 10 HEPES; 300 mosmol/l,
pH 7.4 with Tris). Ca2+-free solutions were obtained by re-
placing CaCl2 with equal amounts of MgCl2 plus 0.5 mM
EGTA and 10 mM Digitonin when indicated.
Store depletion was achieved in Jurkat T cells using anti-CD3
hybridoma SN and crosslinked with a secondary anti-Fc-specific
mouse antibody (Sigma m2650 1:100). CPA was used at 30 mM
and 10 mM in Jurkat and HEK293 cells, respectively.
NFAT nuclear translocation assay and immunostaining
Cells were transfected with NFAT1-GFP plus ORMDL3,
ORMDL3-D1-16 or with siRNAs. After transfection, the
cells were seeded on poly-L-lysine pretreated coverslips at
the indicated time lapses. The cells were fixed with 4% paraf-
ormaldehyde for 15 min and nuclear staining was performed
for 10 min with TO-PRO3. NFAT translocation was calculated
as the ratio of nuclear NFAT-GFP signal to total NFAT1-GFP.
Colocalization experiments were performed in the cells
transfected with STIM-CFP and Orai-YFP. After fixation,
immunostaining for ORMDL3 was done using a commercial
anti-ORMDL3 antibody (1:100, Abgent). Briefly, the cells
were permeabilized for 10 min with 0.1% Triton in phosphate
buffered saline (PBS). Blocking and antibody incubating solu-
tion contained 2% FBS, 1% BSA and 0.5% Triton in PBS.
Images were acquired using an inverted Leica SP2 confocal
microscope with a 40× 1.32 Oil Ph3 CS objective and ana-
lyzed using ImageJ software.
IL2 intracellular staining
Cells transfected with ORMDL3-WT, ORMDL3-D1-16 or
siRNAs plus GFP were washed twice with ice-cold PBS
solution and fixed with paraformaldehyde at 4%. The cells
were then permeabilized and blocked with 2% BSA plus
0.5% saponin (in PBS). Intracellular IL-2 staining was
carried out using PE rat anti-human IL-2 (BD Pharmagen).
LSRII (Beckton Dickinson) 488 laser was used to gate trans-
fected cells and 575/25 filter to evaluate IL2 (PE)-positive
cells.
Electrophysiology
Patch-clamp experiments were performed in the whole-cell
configuration with fire-polished patch pipettes (3 to 4 MV).
Pipette and cell capacitance were electronically compensated
before each voltage ramp with an EPC-10 patch-clamp ampli-
fier controlled by Patchmaster software (HEKA). Membrane
currents were filtered at 2.9 kHz and digitized at a sampling
rate of 10 kHz. Whole-cell currents were elicited by 50 ms
voltage ramps from 2100 (2120 in CDI experiments) to
+100 mV from a holding potential of 0 mV. All currents
were normalized by cell capacitance. For leak current correc-
tion, the ramp current before CRAC activation was subtracted.
No differences (P . 0.05) in the mean cell capacitance were
recorded on cells used under different experimental condi-
tions: ORMDL3 4.9+ 0.2 pF; ORMDL3-△N 4.8+ 0.2 pF;
empty vector 4.4+ 0.3 pF; siControl 5.5+ 0.2 pF;
siORMDL3 5.5+ 0.3 pF; DMSO 5.3+ 0.6 pF; myriocin
4.9+ 0.6 pF. Mean+SEM, n ¼ 5–13.
Two methods were used to trigger ICRAC. Passive depletion
with pipettes filled with a solution containing (in mM): 140
cesium aspartate, 10 NaCl, 5 MgCl2, 10 EGTA (replaced by
BAPTA in BAPTA experiment) and 10 HEPES (pH 7.2
with CsOH). The external solution contained (in mM): 155
NaCl, 4.5 KCl, 10 CaCl2, 2 MgCl2, 10 glucose, and 5
HEPES (pH 7.4 with NaOH). For CDI, pipette internal solu-
tion contained (in mM): 140 cesium aspartate, 2 MgCl2, 0.66
CaCl2, 1.2 EGTA, 10 HEPES (pH 7.2 with CsOH). To evalu-
ate CDI of ICRAC, the cells were seeded in 0 Ca
2+ external so-
lution containing (in mM): 135 NaCl, 4.5 KCl, 3 MgCl2, 0.5
EGTA, 10 glucose, 5 HEPES (pH 7.4 with NaOH). After
obtaining the whole-cell configuration, the cells were incu-
bated for 3 min in 0 Ca2+ external solution + 1 mM TG to
completely deplete internal calcium stores and then switch
to a solution containing 20 mM Ca2+. All experiments were
carried out at room temperature. The calculation of ICRAC
delay was carried out using the plateau function followed by
one phase association of the Graph Pad Prism 5 software.
Statistics
All data were expressed as means+SEM. Statistical analysis
was performed using Student’s t-test or one-way analysis
of variance using SigmaPlot or OriginPro software. Bonferroni’s
test was used for post-hoc comparison of the mean values.
The criterion for a significant difference was a final value of
P, 0.05.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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